Cargando…
Breaking down the cell wall: Still an attractive antibacterial strategy
Since the advent of penicillin, humans have known about and explored the phenomenon of bacterial inhibition via antibiotics. However, with changes in the global environment and the abuse of antibiotics, resistance mechanisms have been selected in bacteria, presenting huge threats and challenges to t...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544107/ https://www.ncbi.nlm.nih.gov/pubmed/36212892 http://dx.doi.org/10.3389/fmicb.2022.952633 |
_version_ | 1784804525942505472 |
---|---|
author | Zhou, Jingxuan Cai, Yi Liu, Ying An, Haoyue Deng, Kaihong Ashraf, Muhammad Awais Zou, Lili Wang, Jun |
author_facet | Zhou, Jingxuan Cai, Yi Liu, Ying An, Haoyue Deng, Kaihong Ashraf, Muhammad Awais Zou, Lili Wang, Jun |
author_sort | Zhou, Jingxuan |
collection | PubMed |
description | Since the advent of penicillin, humans have known about and explored the phenomenon of bacterial inhibition via antibiotics. However, with changes in the global environment and the abuse of antibiotics, resistance mechanisms have been selected in bacteria, presenting huge threats and challenges to the global medical and health system. Thus, the study and development of new antimicrobials is of unprecedented urgency and difficulty. Bacteria surround themselves with a cell wall to maintain cell rigidity and protect against environmental insults. Humans have taken advantage of antibiotics to target the bacterial cell wall, yielding some of the most widely used antibiotics to date. The cell wall is essential for bacterial growth and virulence but is absent from humans, remaining a high-priority target for antibiotic screening throughout the antibiotic era. Here, we review the extensively studied targets, i.e., MurA, MurB, MurC, MurD, MurE, MurF, Alr, Ddl, MurI, MurG, lipid A, and BamA in the cell wall, starting from the very beginning to the latest developments to elucidate antimicrobial screening. Furthermore, recent advances, including MraY and MsbA in peptidoglycan and lipopolysaccharide, and tagO, LtaS, LspA, Lgt, Lnt, Tol-Pal, MntC, and OspA in teichoic acid and lipoprotein, have also been profoundly discussed. The review further highlights that the application of new methods such as macromolecular labeling, compound libraries construction, and structure-based drug design will inspire researchers to screen ideal antibiotics. |
format | Online Article Text |
id | pubmed-9544107 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95441072022-10-08 Breaking down the cell wall: Still an attractive antibacterial strategy Zhou, Jingxuan Cai, Yi Liu, Ying An, Haoyue Deng, Kaihong Ashraf, Muhammad Awais Zou, Lili Wang, Jun Front Microbiol Microbiology Since the advent of penicillin, humans have known about and explored the phenomenon of bacterial inhibition via antibiotics. However, with changes in the global environment and the abuse of antibiotics, resistance mechanisms have been selected in bacteria, presenting huge threats and challenges to the global medical and health system. Thus, the study and development of new antimicrobials is of unprecedented urgency and difficulty. Bacteria surround themselves with a cell wall to maintain cell rigidity and protect against environmental insults. Humans have taken advantage of antibiotics to target the bacterial cell wall, yielding some of the most widely used antibiotics to date. The cell wall is essential for bacterial growth and virulence but is absent from humans, remaining a high-priority target for antibiotic screening throughout the antibiotic era. Here, we review the extensively studied targets, i.e., MurA, MurB, MurC, MurD, MurE, MurF, Alr, Ddl, MurI, MurG, lipid A, and BamA in the cell wall, starting from the very beginning to the latest developments to elucidate antimicrobial screening. Furthermore, recent advances, including MraY and MsbA in peptidoglycan and lipopolysaccharide, and tagO, LtaS, LspA, Lgt, Lnt, Tol-Pal, MntC, and OspA in teichoic acid and lipoprotein, have also been profoundly discussed. The review further highlights that the application of new methods such as macromolecular labeling, compound libraries construction, and structure-based drug design will inspire researchers to screen ideal antibiotics. Frontiers Media S.A. 2022-09-23 /pmc/articles/PMC9544107/ /pubmed/36212892 http://dx.doi.org/10.3389/fmicb.2022.952633 Text en Copyright © 2022 Zhou, Cai, Liu, An, Deng, Ashraf, Zou and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Microbiology Zhou, Jingxuan Cai, Yi Liu, Ying An, Haoyue Deng, Kaihong Ashraf, Muhammad Awais Zou, Lili Wang, Jun Breaking down the cell wall: Still an attractive antibacterial strategy |
title | Breaking down the cell wall: Still an attractive antibacterial strategy |
title_full | Breaking down the cell wall: Still an attractive antibacterial strategy |
title_fullStr | Breaking down the cell wall: Still an attractive antibacterial strategy |
title_full_unstemmed | Breaking down the cell wall: Still an attractive antibacterial strategy |
title_short | Breaking down the cell wall: Still an attractive antibacterial strategy |
title_sort | breaking down the cell wall: still an attractive antibacterial strategy |
topic | Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544107/ https://www.ncbi.nlm.nih.gov/pubmed/36212892 http://dx.doi.org/10.3389/fmicb.2022.952633 |
work_keys_str_mv | AT zhoujingxuan breakingdownthecellwallstillanattractiveantibacterialstrategy AT caiyi breakingdownthecellwallstillanattractiveantibacterialstrategy AT liuying breakingdownthecellwallstillanattractiveantibacterialstrategy AT anhaoyue breakingdownthecellwallstillanattractiveantibacterialstrategy AT dengkaihong breakingdownthecellwallstillanattractiveantibacterialstrategy AT ashrafmuhammadawais breakingdownthecellwallstillanattractiveantibacterialstrategy AT zoulili breakingdownthecellwallstillanattractiveantibacterialstrategy AT wangjun breakingdownthecellwallstillanattractiveantibacterialstrategy |